Simplify Logo

Full-Time

Associate Director

Regional Marketer, Northwest Region

Confirmed live in the last 24 hours

Axsome Therapeutics Inc

Axsome Therapeutics Inc

501-1,000 employees

Develops therapies for CNS disorders

Hardware
Biotechnology

Compensation Overview

$160k - $190kAnnually

+ Bonus + Equity

Senior, Expert

Washington, USA + 6 more

Category
General Marketing
PR & Communications
Growth & Marketing
Required Skills
Sales
Branding/Brand Strategy
Marketing
Requirements
  • BA or BS in relevant field; advanced degree preferred. Plus, a minimum 5-7 years of experience in pharma in CNS
  • Minimum 5-7 years of experience in one of the following: product marketing, thought leader engagement, field sales or management
  • 50-70% business travel, by air or car, is regularly required
  • Must live in the territory's geography
  • Demonstrated success and expertise with thought leader engagement, ad boards and speaker’s bureau- strongly preferred
  • Marketing, sales management, and/or extensive pharmaceutical product launch experience- strongly preferred
  • Proven ability to successfully manage accounts in a large geographical territory including both academic and community-based HCPs
  • Demonstrated ability to build productive stakeholder relationships internally and externally with impactful engagement tactics
  • Clinical knowledge and aptitude in complex/competitive disease states, preferably in the CNS market.
  • Strong intellectual curiosity with a desire to continuously learn and improve by applying new knowledge and skills on the job and innovate with market dynamics
  • Highly collaborative with the ability to manage multiple projects simultaneously
  • Self-starter with strong organizational and planning skills. Able to determine effective approaches and take the appropriate action based on the available information/resources consistent with the over-arching strategy
  • Effective verbal and written communication skills
Responsibilities
  • Function as a thought leader liaison to key KOLs within the community and build bridge to/from customer to Axsome Therapeutics
  • Develop and maintain KOL engagement plans and influence maps for thought leaders
  • Engage with KOLs at local, regional, and national congresses and advocacy events to discuss brand, disease state and commercial strategy as well as facilitate engagements and opportunities for executive leadership in support of marketing initiatives
  • Gather insights from key thought leaders to inform brand strategy and support development of content, tactics, and resources, when appropriate
  • Support cross-functional teams to gather key customer insights and input on the marketplace by garnering insights on commercial strategy, including designing local marketplace tactics, clinical messaging, access, and educational needs.
  • Supporting the execution of approved Commercial Advisory Boards
  • Assist in identification of Healthcare Professional (HCP) consultants based on profile established by the approved Consultant Engagement Project Brief
  • Design, Facilitate, participate in, and attend advisory boards, where appropriate
  • Identify and develop HCP and access speakers to provide compliant, high-quality speaker programs on disease state, mechanism of disease, and product, when appropriate
  • Ensure appropriate and compliant execution of speaker programs
  • Monitor speaker performance at events and develops speakers to provide high quality promotional education through coaching as needed
  • Work with Marketing and contracted speakers to gain and synthesize feedback on current and future content development
Axsome Therapeutics Inc

Axsome Therapeutics Inc

View

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain to help regulate mood. This drug has shown positive results in clinical trials and has received FDA Breakthrough Therapy Designation, which speeds up its development process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and clinical trials. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

Company Stage

IPO

Total Funding

$430.7M

Headquarters

New York City, New York

Founded

2012

Growth & Insights
Headcount

6 month growth

92%

1 year growth

92%

2 year growth

92%
Simplify Jobs

Simplify's Take

What believers are saying

  • The launch of Auvelity and the promising results of AXS-12 in Phase 3 trials indicate strong potential for revenue growth and market impact.
  • Axsome's strategic expansion of its sales force to support Auvelity's launch demonstrates its commitment to commercial success.
  • The appointment of experienced leaders like Dr. Sue Mahony to the board enhances Axsome's strategic direction and governance.

What critics are saying

  • The biopharmaceutical sector's inherent risks, including regulatory hurdles and clinical trial failures, could impact Axsome's progress.
  • High competition in the CNS disorder treatment market may challenge Axsome's ability to capture significant market share.

What makes Axsome Therapeutics Inc unique

  • Axsome Therapeutics focuses on CNS disorders with a strong emphasis on unmet medical needs, setting it apart from broader biopharmaceutical companies.
  • The FDA Breakthrough Therapy Designation for AXS-05 highlights its innovative approach and potential for rapid market entry.
  • Axsome's diversified pipeline, including treatments for MDD, TRD, Alzheimer's agitation, and narcolepsy, showcases its comprehensive strategy in CNS therapeutics.